388 related articles for article (PubMed ID: 28691147)
21. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
[TBL] [Abstract][Full Text] [Related]
22. Perioperative changes in prouroguanylin hormone response in severely obese subjects after bariatric surgery.
Torquati A; Shantavasinkul PC; Omotosho P; Corsino L; Spagnoli A
Surgery; 2019 Oct; 166(4):456-459. PubMed ID: 31472974
[TBL] [Abstract][Full Text] [Related]
23. Roux-en-Y gastric bypass surgery in youth with severe obesity: 1-year longitudinal changes in spexin.
Kumar S; Hossain MJ; Inge T; Balagopal PB
Surg Obes Relat Dis; 2018 Oct; 14(10):1537-1543. PubMed ID: 30131311
[TBL] [Abstract][Full Text] [Related]
24. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
[TBL] [Abstract][Full Text] [Related]
25. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
26. The Reduction of Visceral Adipose Tissue after Roux-en-Y Gastric Bypass Is more Pronounced in Patients with Impaired Glucose Metabolism.
Favre L; Marino L; Roth A; Acierno J; Hans D; Demartines N; Pitteloud N; Suter M; Collet TH
Obes Surg; 2018 Dec; 28(12):4006-4013. PubMed ID: 30109666
[TBL] [Abstract][Full Text] [Related]
27. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.
Camastra S; Gastaldelli A; Mari A; Bonuccelli S; Scartabelli G; Frascerra S; Baldi S; Nannipieri M; Rebelos E; Anselmino M; Muscelli E; Ferrannini E
Diabetologia; 2011 Aug; 54(8):2093-102. PubMed ID: 21614570
[TBL] [Abstract][Full Text] [Related]
28. Outcomes in glycemic control in the intermediate follow-up of Roux-en-Y gastric bypass: a Brazilian cohort study.
Beleigoli AM; Coelho AL; Diniz MT; Lages Savassi-Rocha A; Diniz Mde F
Surg Obes Relat Dis; 2014; 10(6):1022-7. PubMed ID: 25445150
[TBL] [Abstract][Full Text] [Related]
29. Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation.
Kratz M; Hagman DK; Kuzma JN; Foster-Schubert KE; Chan CP; Stewart S; van Yserloo B; Westbrook EO; Arterburn DE; Flum DR; Cummings DE
Obesity (Silver Spring); 2016 Jul; 24(7):1438-45. PubMed ID: 27228052
[TBL] [Abstract][Full Text] [Related]
30. Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.
Griffo E; Cotugno M; Nosso G; Saldalamacchia G; Mangione A; Angrisani L; Rivellese AA; Capaldo B
Obes Surg; 2016 Jun; 26(6):1247-53. PubMed ID: 26435537
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy achieve comparable weight loss at 1 year.
Yaghoubian A; Tolan A; Stabile BE; Kaji AH; Belzberg G; Mun E; Zane R
Am Surg; 2012 Dec; 78(12):1325-8. PubMed ID: 23265120
[TBL] [Abstract][Full Text] [Related]
32. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
[TBL] [Abstract][Full Text] [Related]
33. Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D.
Katsogiannos P; Kamble PG; Boersma GJ; Karlsson FA; Lundkvist P; Sundbom M; Pereira MJ; Eriksson JW
J Clin Endocrinol Metab; 2019 Jul; 104(7):2601-2613. PubMed ID: 30689903
[TBL] [Abstract][Full Text] [Related]
34. Resting energy expenditure after Roux-en Y gastric bypass surgery.
Wilms B; Ernst B; Thurnheer M; Schmid SM; Spengler CM; Schultes B
Surg Obes Relat Dis; 2018 Feb; 14(2):191-199. PubMed ID: 29275093
[TBL] [Abstract][Full Text] [Related]
35. Non-responders After Gastric Bypass Surgery for Morbid Obesity: Peptide Hormones and Glucose Homeostasis.
Sima E; Webb DL; Hellström PM; Sundbom M
Obes Surg; 2019 Dec; 29(12):4008-4017. PubMed ID: 31338735
[TBL] [Abstract][Full Text] [Related]
36. Gastric Bypass Resolves Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Low-BMI Patients: A Prospective Cohort Study.
Billeter AT; Scheurlen KM; Israel B; Straub BK; Schirmacher P; Kopf S; Nawroth PP; Müller-Stich BP
Ann Surg; 2022 Nov; 276(5):814-821. PubMed ID: 35880762
[TBL] [Abstract][Full Text] [Related]
37. Changes in Bone Marrow Adipose Tissue One Year After Roux-en-Y Gastric Bypass: A Prospective Cohort Study.
Blom-Høgestøl IK; Mala T; Kristinsson JA; Hauge EM; Brunborg C; Gulseth HL; Eriksen EF
J Bone Miner Res; 2019 Oct; 34(10):1815-1823. PubMed ID: 31216081
[TBL] [Abstract][Full Text] [Related]
38. Changes in oxidative stress markers and cardiometabolic risk factors among Roux-en-Y gastric bypass patients after 3- and 12-months postsurgery follow-up.
Pinto SL; Juvanhol LL; Licursi de Oliveira L; Clemente RC; Bressan J
Surg Obes Relat Dis; 2019 Oct; 15(10):1738-1745. PubMed ID: 31495634
[TBL] [Abstract][Full Text] [Related]
39. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
[TBL] [Abstract][Full Text] [Related]
40. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
